Citadel Advisors
FLACW

Citadel Advisors’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Citadel Advisors’s Portfolio FLACW Stock Details FLACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,495
Closed -$1K – 14423
2022
Q2 		$1K Sell
10,495
-156,612
-94% -$27.2K ﹤0.01% 12744
2022
Q1 		$38K Sell
167,107
-9,192
-5% -$3.99K ﹤0.01% 12981
2021
Q4 		$102K Sell
176,299
-4,633
-3% -$3.23K ﹤0.01% 12710
2021
Q3 		$114K Sell
180,932
-2,400
-1% -$2.15K ﹤0.01% 12711
2021
Q2 		$204K Hold
183,332
– – ﹤0.01% 12122
2021
Q1 		$165K Buy
+183,332
New +$310K ﹤0.01% 11940

Other funds holding FLACW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.39B AUM 64.83% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $424M AUM 77.08% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
AI
Arena Investors Purchase, New York $5.88M AUM 0.27% 1-Year Est. Return